Treace Medical Concepts, Inc. (TMCI)

Treace Medical Concepts Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	212.69	209.36	187.12	141.84	94.42
Revenue Growth (YoY)	1.59%	11.88%	31.92%	50.22%	64.59%
Cost of Revenue	42.94	41.09	35.18	25.53	16.89
Gross Profit	169.75	168.26	151.94	116.31	77.53
Selling, General & Admin	203.62	203.36	187.93	137.57	83.84
Research & Development	20.28	20.59	15.44	13.58	10.2
Total Operating Expenses	223.91	223.95	203.37	151.15	94.04
Operating Income	-54.15	-55.69	-51.43	-34.84	-16.51
Interest Income	2.78	4.88	6.73	1.31	0.02
Interest Expense	-5.32	-5.26	-5.17	-4.4	-4.06
Other Non-Operating Income (Expense)	-7.15	0.27	2.24	-12.86	-4.04
Total Non-Operating Income (Expense)	-9.7	-0.11	3.8	-15.94	-8.08
Pretax Income	-63.85	-55.8	-47.63	-50.79	-24.59
Net Income	-59	-55.74	-49.53	-42.82	-20.75
Net Income Attributable to Preferred Dividends	-	-	-	-	0.2
Net Income to Common	-59	-55.74	-49.53	-42.82	-20.75
Shares Outstanding (Basic)	63	62	61	55	48
Shares Outstanding (Diluted)	63	62	61	55	48
Shares Change (YoY)	1.86%	2.07%	10.09%	14.17%	30.61%
EPS (Basic)	-0.93	-0.90	-0.81	-0.77	-0.43
EPS (Diluted)	-0.93	-0.90	-0.81	-0.77	-0.43
Free Cash Flow	-29.49	-48.76	-46.03	-45.49	-19.9
Free Cash Flow Per Share	-0.47	-0.79	-0.76	-0.82	-0.41
Gross Margin	79.81%	80.37%	81.20%	82.00%	82.11%
Operating Margin	-25.46%	-26.60%	-27.48%	-24.57%	-17.49%
Profit Margin	-27.74%	-26.63%	-26.47%	-30.19%	-21.77%
FCF Margin	-13.86%	-23.29%	-24.60%	-32.07%	-21.07%
EBITDA	-43.53	-47.27	-46.08	-32.71	-15.83
EBITDA Margin	-20.47%	-22.58%	-24.62%	-23.06%	-16.76%
EBIT	-54.15	-55.69	-51.43	-34.84	-16.51
EBIT Margin	-25.46%	-26.60%	-27.48%	-24.57%	-17.49%

Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q